Analyzing survival data in conjunction with time-dependent surrogate endpoints in clinical trials

DOI10.1080/03610929508831617MaRDI QIDQ4337068zbMATH OpenOpenAlexFDO

Authors Gail E. Tudor, Timothy M. Morgan

Publication date 13 June 2000

Published in Communications in Statistics: Theory and Methods (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/03610929508831617

zbMATH Keywords

clinical trialssurvival analysistime-dependent covariatessurrogate measure

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data
• A Nonparametric Approach to a Survival Study with Surrogate Endpoints
• Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
• Using surrogate failure time data to increase cost effectiveness in clinical trials
• The Evaluation of Multiple Surrogate Endpoints

Cites work

• A Stochastic Model for Censored-Survival Data in the Presence of an Auxiliary Variable
• Sample-Size Formula for the Proportional-Hazards Regression Model

Cited in

(10)

• Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time
• Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
• The time-dependent ``cure-death model investigating several endpoints simultaneously in trials treating high-risk patients with severe infections
• Using surrogate failure time data to increase cost effectiveness in clinical trials
• Survival analysis of cancer patients with multiple endpoints using global score test methodology
• Analyzing survival curves at a fixed point in time for paired and clustered right-censored data
• Times of analgesic efficacy of two drugs in the treatment of patients with renal-ureteral colic compared by survival models
• A Nonparametric Approach to a Survival Study with Surrogate Endpoints
• Comparing treatment strategies using a synthesized clinical trial: an analysis of late versus early use of trimethoprim-sulfamethoxazole for AIDS patients.
• Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a threshold

This page was built for publication: Analyzing survival data in conjunction with time-dependent surrogate endpoints in clinical trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4337068)